Literature DB >> 16000932

Band ligation plus sclerotherapy versus sclerotherapy alone in children with extrahepatic portal venous obstruction.

Ujjal Poddar1, Babu Ram Thapa, Kartar Singh.   

Abstract

Although endoscopic band ligation (EVL) plus sclerotherapy (EST) has shown to be superior to any individual method, there is no study in children. We therefore analyzed our experience of EST and EVL + EST in children with extrahepatic portal venous obstruction (EHPVO). Over a period of 8 years, 136 children who presented with a history of recent variceal bleeding due to EHPVO were studied; 30 of them received EVL + EST and 106 received EST alone. In the EVL + EST group, after the first session of EVL, EST was done three times weekly until variceal eradication was achieved. The mean age of these children was 7 +/- 3.6 years with a male-to-female ratio of 2.6:1. The rate of eradication was comparable in both groups (100% in EVL + EST and 96% in EST). However, EVL + EST group required a significantly fewer sessions and lower volume of sclerosant (2 +/- 1 vs. 4.4 +/- 2 sessions, P < 0.001 and 3.1 +/- 2 mL versus 7.5 +/- 4 mL, P < 0.001 respectively). There were significantly less complications in EVL + EST group (10% vs. 36%, P < 0.01). Over a mean follow-up of 27 months, varices recurred in 6.6% and 10% cases, respectively. EVL + EST is a better method in the treatment of esophageal varices in children with EHPVO than EST alone, as it required fewer session and had fewer complication.

Entities:  

Mesh:

Year:  2005        PMID: 16000932     DOI: 10.1097/01.mcg.0000170765.36825.66

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

Review 1.  Interventional upper endoscopy: the pediatric perspective.

Authors:  Steven Liu; Petar Mamula; Chris A Liacouras
Journal:  Curr Gastroenterol Rep       Date:  2006-12

Review 2.  Portal vein thrombosis.

Authors:  Yogesh K Chawla; Vijay Bodh
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

3.  Revisiting extra hepatic portal vein obstruction in children from the north Indian gangetic plain.

Authors:  Sundeep Goyal; V K Dixit; A K Jain; O P Mishra; S K Jena; Jayant Ghosh
Journal:  Indian J Pediatr       Date:  2013-10-10       Impact factor: 1.967

Review 4.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

5.  Surgical treatment of massive splenomegaly and severe hypersplenism secondary to extrahepatic portal venous obstruction in children.

Authors:  Roy Choudhury Subhasis; Chadha Rajiv; Sharma Akshay Kumar; Anand Vinod Kumar; Patwari Ashok Kumar
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

6.  Experiences with endoscopic interventions for variceal bleeding in children with portal hypertension: a single center study.

Authors:  Seung Jin Kim; Seak Hee Oh; Jin Min Jo; Kyung Mo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-12-31

Review 7.  Recent trends in the endoscopic management of variceal bleeding in children.

Authors:  Seung Jin Kim; Kyung Mo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-03-31

8.  Management of bleeding in extrahepatic portal venous obstruction.

Authors:  N Chaudhary; S Mehrotra; M Srivastava; S Nundy
Journal:  Int J Hepatol       Date:  2013-06-25

9.  Endoscopic management of bleeding gastric varices with N-butyl, 2-cyanoacrylate glue injection in children with non-cirrhotic portal hypertension.

Authors:  Ujjal Poddar; Vibhor Borkar; Surender Kumar Yachha; Anshu Srivastava
Journal:  Endosc Int Open       Date:  2016-09-29

10.  Endoscopic prophylaxis and factors associated with bleeding in children with extrahepatic portal vein obstruction.

Authors:  Ana Paula Pereira de Oliveira; Alexandre Rodrigues Ferreira; Eleonora Druve Tavares Fagundes; Thaís Costa Nascentes Queiroz; Simone Diniz Carvalho; José Andrade Franco Neto; Paulo Fernando Souto Bittencourt
Journal:  J Pediatr (Rio J)       Date:  2019-10-27       Impact factor: 2.990

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.